Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2023-05-18 Annual Report
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Annual Report Classification · 95% confidence The document is a detailed financial statement from Ajooni Biotech Limited, including audited financial results for the year ended March 31, 2023, auditor's report, and comprehensive financial data such as income, expenses, assets, liabilities, and equity. It references the Board Meeting outcome where these audited financial results were approved. The document contains substantive financial data and analysis for the full fiscal year, indicating it is a full annual financial report. The presence of audited financial results and detailed balance sheet and profit & loss data confirms this is an Annual Report. It is not a short announcement or a certification letter, but a full report with financial statements and notes. Therefore, the appropriate classification is Annual Report (10-K).
2023-05-18 English
Financial Result Updates
Regulatory Filings
2023-05-18 English
Outcome of Board Meeting
Regulatory Filings
2023-05-18 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a short notice informing the stock exchange about an upcoming Board Meeting scheduled for May 18, 2023. The purpose of the meeting includes approval of audited financial results for the fiscal year ended March 31, 2023. The document is an intimation or announcement of a board meeting rather than the meeting minutes or the financial results themselves. It does not contain any financial data or detailed report content. Therefore, it fits the category of Board/Management Information (MANG), which covers announcements related to board meetings and management activities.
2023-05-10 English
Board Meeting — AJOONI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 18-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the…
Regulatory Filings
2023-05-10 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Ltd, confirming that Ajooni Biotech Limited does not meet the criteria of a 'Large Corporate' entity as per SEBI circulars related to fund raising by issuance of debt securities. It references specific SEBI circulars and provides a disclosure table with company details and borrowing status. The document is dated April 28, 2023, and signed by company officials. The content is a regulatory compliance confirmation rather than a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. The document length is 3068 characters, which is relatively short and consistent with a regulatory filing or compliance confirmation. Therefore, this document fits best under Regulatory Filings (RNS) as it is a formal regulatory announcement confirming non-applicability of large corporate criteria under SEBI guidelines.
2023-04-28 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.